CN1191232C - 氨甲基羧酸衍生物 - Google Patents
氨甲基羧酸衍生物 Download PDFInfo
- Publication number
- CN1191232C CN1191232C CNB998086649A CN99808664A CN1191232C CN 1191232 C CN1191232 C CN 1191232C CN B998086649 A CNB998086649 A CN B998086649A CN 99808664 A CN99808664 A CN 99808664A CN 1191232 C CN1191232 C CN 1191232C
- Authority
- CN
- China
- Prior art keywords
- acid
- methyl
- aminomethylcarboxyliacid
- phenyl
- ylmethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Abstract
Description
实施例 | 化合物 | pIC50 |
(+/-)- 4 | (+/-)-顺式-N-甲基-N-(6-甲氧基-1-苯基-1,2,3,4-四氢化萘-2-基甲基)氨甲基羧酸锂 | 6.3 |
(-)- 4 | (-)-顺式-N-甲基-N-(6-甲氧基-1-苯基-1,2,3,4-四氢化萘-2-基甲基)氨甲基羧酸锂 | 6.8 |
(+/-)- 8 | (+/-)-N-甲基-N-[1-(4-氟苯基)-6-三氟甲基-1,2,3,4-四氢化萘-2-基甲基]氨甲基羧酸锂 | 6.9 |
(-)- 8 | (-)-N-甲基-N-[1-(4-氟苯基)-6-三氟甲基-1,2,3,4-四氢化萘-2-基甲基]氨甲基羧酸锂 | 7.3 |
(+/-)- 17 | (+/-)-顺式-N-甲基-N-(6-苯氧基-1-苯基-1,2,3,4-四氢化萘-2-基甲基)氨甲基羧酸钠 | 6.8 |
(-)- 17 | (-)-顺式-N-甲基-N-(6-苯氧基-1-苯基-1,2,3,4-四氢化萘-2-基甲基)氨甲基羧酸钠 | 7.0 |
(+/-)- 23 | (+/-)-顺式-N-甲基-N-(6-甲基-1-苯基-1,2,3,4-四氢化萘-2-基甲基)氨甲基羧酸钠 | 6.6 |
(-)- 23 | (-)-顺式-N-甲基-N-(6-甲基-1-苯基-1,2,3,4-四氢化萘-2-基甲基)氨甲基羧酸钠 | 6.9 |
(+/-)- 34 | (+/-)-顺式-N-甲基-N-[1-苯基-6-(2,2-二甲基丙氧基)-1,2,3,4-四氢化萘-2-基甲基]氨甲基羧酸锂 | 6.6 |
(-)- 34 | (-)-顺式-N-甲基-N-[1-苯基-6-(2,2-二甲基丙氧基)-1,2,3,4-四氢化萘-2-基甲基]氨甲基羧酸锂 | 6.6 |
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98306149 | 1998-07-31 | ||
EP98306149.0 | 1998-07-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1309631A CN1309631A (zh) | 2001-08-22 |
CN1191232C true CN1191232C (zh) | 2005-03-02 |
Family
ID=8234975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB998086649A Expired - Lifetime CN1191232C (zh) | 1998-07-31 | 1999-07-26 | 氨甲基羧酸衍生物 |
Country Status (28)
Country | Link |
---|---|
US (1) | US6410592B1 (zh) |
EP (1) | EP1100769B1 (zh) |
JP (1) | JP4290340B2 (zh) |
KR (1) | KR100640031B1 (zh) |
CN (1) | CN1191232C (zh) |
AR (1) | AR049670A1 (zh) |
AT (1) | ATE228995T1 (zh) |
AU (1) | AU762759B2 (zh) |
BR (1) | BR9912621A (zh) |
CA (1) | CA2337041C (zh) |
CO (1) | CO5080746A1 (zh) |
CZ (1) | CZ301620B6 (zh) |
DE (1) | DE69904335T2 (zh) |
DK (1) | DK1100769T3 (zh) |
ES (1) | ES2189462T3 (zh) |
HK (1) | HK1035525A1 (zh) |
HU (1) | HUP0102766A3 (zh) |
ID (1) | ID26978A (zh) |
IL (1) | IL140358A0 (zh) |
NO (1) | NO327756B1 (zh) |
NZ (1) | NZ509568A (zh) |
PL (1) | PL198041B1 (zh) |
PT (1) | PT1100769E (zh) |
RU (1) | RU2225389C2 (zh) |
SK (1) | SK286474B6 (zh) |
TR (1) | TR200100270T2 (zh) |
TW (1) | TW555757B (zh) |
WO (1) | WO2000007978A1 (zh) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI243173B (en) | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
DE102004030099A1 (de) * | 2004-06-22 | 2006-01-12 | Grünenthal GmbH | Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren |
RU2007130941A (ru) * | 2005-01-14 | 2009-02-20 | Н.В. Органон (Nl) | Ингибиторы повторного поглощения глицина для лечения зависимости от наркотиков и алкоголя |
ES2566479T3 (es) * | 2006-01-06 | 2016-04-13 | Sunovion Pharmaceuticals Inc. | Inhibidores de reabsorción de monoamina con base en tetralona |
JP2011502974A (ja) * | 2007-11-06 | 2011-01-27 | ナームローゼ・フエンノートチヤツプ・オルガノン | ヒトにおけるホルモン抑制の方法 |
AR075442A1 (es) | 2009-02-16 | 2011-03-30 | Abbott Gmbh & Co Kg | Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia |
EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
US8883839B2 (en) | 2010-08-13 | 2014-11-11 | Abbott Laboratories | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9045459B2 (en) * | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9051280B2 (en) | 2010-08-13 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8877794B2 (en) | 2010-08-13 | 2014-11-04 | Abbott Laboratories | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8846743B2 (en) | 2010-08-13 | 2014-09-30 | Abbott Laboratories | Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
US8853196B2 (en) | 2011-08-05 | 2014-10-07 | AbbVie Deutschland GmbH & Co. KG | Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
KR102021162B1 (ko) | 2011-11-01 | 2019-09-11 | 메르크 파텐트 게엠베하 | 유기 전계발광 소자 |
US10305040B2 (en) | 2011-11-17 | 2019-05-28 | Merck Patent Gmbh | Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices |
CN104011028A (zh) | 2011-11-18 | 2014-08-27 | 艾伯维德国有限责任两合公司 | N-取代的氨基苯并环庚烯、氨基四氢化萘、氨基茚满和苯烷基胺衍生物、包含所述衍生物的药物组合物及其在治疗中的用途 |
US9365512B2 (en) | 2012-02-13 | 2016-06-14 | AbbVie Deutschland GmbH & Co. KG | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
JP6105040B2 (ja) | 2012-03-23 | 2017-03-29 | メルク パテント ゲーエムベーハー | エレクトロルミネッセンス素子のための9,9’−スピロビキサンテン誘導体 |
US9650334B2 (en) | 2013-03-15 | 2017-05-16 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
US9656955B2 (en) | 2013-03-15 | 2017-05-23 | Abbvie Inc. | Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy |
JP2016533375A (ja) * | 2013-10-17 | 2016-10-27 | アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー | アミノテトラリン誘導体およびアミノインダン誘導体、これらを含有する医薬組成物、および治療におけるこれらの使用 |
CN105992764A (zh) | 2013-10-17 | 2016-10-05 | 艾伯维德国有限责任两合公司 | 氨基色满、氨基硫代色满及氨基-1,2,3,4-四氢喹啉衍生物,包含其的药物组合物及其在治疗中的用途 |
CN104844471B (zh) * | 2015-04-21 | 2017-05-03 | 苏州远智医药科技有限公司 | 一种作为dor受体拮抗剂的化合物 |
US10226442B2 (en) * | 2017-07-10 | 2019-03-12 | Syneurx International (Taiwan) Corp. | Lithium salts of N-substituted glycine compounds and uses thereof |
CN111108105B (zh) | 2017-09-22 | 2023-03-31 | 朱比兰特埃皮帕德有限公司 | 作为pad抑制剂的杂环化合物 |
SG11202003463XA (en) | 2017-10-18 | 2020-05-28 | Jubilant Epipad LLC | Imidazo-pyridine compounds as pad inhibitors |
CA3080677A1 (en) | 2017-11-06 | 2019-05-09 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
IL274762B2 (en) | 2017-11-24 | 2023-10-01 | Jubilant Episcribe Llc | Novel heterocyclic compounds as PRMT5 inhibitors |
SG11202008950PA (en) | 2018-03-13 | 2020-10-29 | Jubilant Prodel LLC | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
CN110003160B (zh) * | 2019-05-14 | 2022-10-11 | 贵州中医药大学 | 一种蛇床子素腙类/酰腙类/磺酰腙类衍生物及其制备方法以及应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5657157A (en) * | 1995-06-23 | 1997-08-12 | Sdl, Inc. | Semiconductor optical amplifying media with reduced self-focusing |
PL186781B1 (pl) * | 1995-09-29 | 2004-02-27 | Glaxo Wellcome Spa | Nowy związek, pochodna tetrahydrochinoliny, sposób wytwarzania pochodnej tetrahydrochinoliny, środek farmaceutyczny i zastosowanie |
CA2255727A1 (en) * | 1996-05-31 | 1997-12-04 | Trophix Pharmaceuticals, Inc. | Pharmaceutical for treating of neurological and neuropsychiatric disorders |
DK1014966T3 (da) | 1996-05-31 | 2006-12-04 | Allelix Neuroscience Inc | Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser |
-
1999
- 1999-07-23 TW TW088112566A patent/TW555757B/zh not_active IP Right Cessation
- 1999-07-26 SK SK149-2001A patent/SK286474B6/sk not_active IP Right Cessation
- 1999-07-26 CN CNB998086649A patent/CN1191232C/zh not_active Expired - Lifetime
- 1999-07-26 RU RU2001105536/04A patent/RU2225389C2/ru not_active IP Right Cessation
- 1999-07-26 AU AU53724/99A patent/AU762759B2/en not_active Expired
- 1999-07-26 CA CA002337041A patent/CA2337041C/en not_active Expired - Lifetime
- 1999-07-26 NZ NZ509568A patent/NZ509568A/en not_active IP Right Cessation
- 1999-07-26 KR KR1020017001327A patent/KR100640031B1/ko not_active IP Right Cessation
- 1999-07-26 IL IL14035899A patent/IL140358A0/xx not_active IP Right Cessation
- 1999-07-26 ES ES99939419T patent/ES2189462T3/es not_active Expired - Lifetime
- 1999-07-26 JP JP2000563613A patent/JP4290340B2/ja not_active Expired - Lifetime
- 1999-07-26 EP EP99939419A patent/EP1100769B1/en not_active Expired - Lifetime
- 1999-07-26 BR BR9912621-4A patent/BR9912621A/pt not_active Application Discontinuation
- 1999-07-26 TR TR2001/00270T patent/TR200100270T2/xx unknown
- 1999-07-26 ID IDW20010234A patent/ID26978A/id unknown
- 1999-07-26 PL PL345794A patent/PL198041B1/pl not_active IP Right Cessation
- 1999-07-26 HU HU0102766A patent/HUP0102766A3/hu unknown
- 1999-07-26 AT AT99939419T patent/ATE228995T1/de active
- 1999-07-26 WO PCT/EP1999/005477 patent/WO2000007978A1/en active Search and Examination
- 1999-07-26 DE DE69904335T patent/DE69904335T2/de not_active Expired - Lifetime
- 1999-07-26 DK DK99939419T patent/DK1100769T3/da active
- 1999-07-26 US US09/744,520 patent/US6410592B1/en not_active Expired - Lifetime
- 1999-07-26 PT PT99939419T patent/PT1100769E/pt unknown
- 1999-07-26 CZ CZ20010398A patent/CZ301620B6/cs not_active IP Right Cessation
- 1999-07-29 AR ARP990103756A patent/AR049670A1/es active IP Right Grant
- 1999-07-30 CO CO99048379A patent/CO5080746A1/es unknown
-
2001
- 2001-01-30 NO NO20010514A patent/NO327756B1/no not_active IP Right Cessation
- 2001-09-04 HK HK01106227A patent/HK1035525A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1191232C (zh) | 氨甲基羧酸衍生物 | |
CN1910154A (zh) | 用作分枝杆菌抑制剂的喹啉衍生物 | |
CN1131214C (zh) | 作为兴奋性氨基酸拮抗剂的四氢喹啉衍生物 | |
CN1039248A (zh) | 新的二磷酸衍生物的制备方法 | |
CN1045971A (zh) | 新的喹诺酮衍生物,它们的制备方法以及含有此类衍生物的抗菌剂 | |
CN1199974C (zh) | 作为甘氨酸转运抑制剂的螺(2h-1-苯并吡喃-2,4’-哌啶)衍生物 | |
CN1910177A (zh) | 取代的喹啉及其作为分枝杆菌抑制剂的用途 | |
CN1100095A (zh) | 螺环化合物的制备 | |
CN100351244C (zh) | 双芳族链烷醇 | |
CN1082964C (zh) | 手性的双膦类化合物 | |
CN1784408A (zh) | 8-取代的-6,7,8,9-四氢嘧啶并[1,2-a]嘧啶-4-酮衍生物 | |
CN1037441C (zh) | 二环胺衍生物及含有该衍生物的抗菌剂 | |
CN101065361A (zh) | 具有取代己内酰胺环的bengamides,其制备方法,含有它们的组合物与其用途 | |
CN1067053C (zh) | 单环β-内酰胺类抗生素衍生物的中间体的制备方法 | |
CN1798744A (zh) | 作为nmda/nr2b拮抗剂的3-氟-哌啶化合物 | |
CN1054980A (zh) | 具有旋光活性的8-甲氧基喹诺酮羧酸衍生物,它们的制备方法以及它们的中间体 | |
CN1069969A (zh) | 作为兴奋性氨基酸神经递质拮抗剂的合成芳基多胺 | |
CN1099032A (zh) | 苯并噁嗪衍生物,其制备方法及其药用 | |
CN1033029C (zh) | 茚并吲哚化合物的制备方法 | |
CN1025334C (zh) | 新的谷氨酸衍生物的制备方法 | |
CN1041731C (zh) | 吡啶并[1,2,3—d,e][1,3,4]苯并噁二嗪衍生物 | |
CN1777603A (zh) | 取代的2-(二氮杂-双环-烷基)-嘧啶酮衍生物 | |
CN1055472C (zh) | 噁唑并喹啉酮衍生物,它们的制备及其在治疗上的应用 | |
CN1028102C (zh) | 螺环化合物的制备 | |
CN1254476C (zh) | 二氢咪唑并[5,1-a]-β-咔啉衍生物,其制备方法和作为药物的用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ORGANON NV Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20070105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070105 Address after: Holland Patentee after: N.V. ORGANON Address before: Holland Arnhem Patentee before: AKZO NOBEL N.V. |
|
C56 | Change in the name or address of the patentee |
Owner name: MSD OS CO., LTD. Free format text: FORMER NAME: ORGANON NV |
|
CP01 | Change in the name or title of a patent holder |
Address after: Holland Patentee after: N.V. Organon Address before: Holland Patentee before: N.V. ORGANON |
|
ASS | Succession or assignment of patent right |
Owner name: MERCK SHARP + DOHME CORP. Free format text: FORMER OWNER: ORGANON BIOLOGICAL NETHERLANDS CO., LTD. Effective date: 20131014 Owner name: ORGANON BIOLOGICAL NETHERLANDS CO., LTD. Free format text: FORMER OWNER: MSD OUSI CO., LTD. Effective date: 20131014 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20131014 Address after: Haarlem Patentee after: MERCK SHARP & DOHME B.V. Address before: Haarlem Patentee before: Organon biological science Holland Co.,Ltd. Effective date of registration: 20131014 Address after: Haarlem Patentee after: Organon biological science Holland Co.,Ltd. Address before: Holland Patentee before: N.V. Organon |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050302 |